This announcement is a separate document:
ノイルイミューン・バイオテック：NIB102およびNIB103の武田薬品からの返還について
Noile-Immune Biotech: Regarding the return of NIB102 and NIB103 to Takeda Pharmaceutical.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.